Primary Pulmonary Hypertension (”PPH”) and FEN-PHEN Attorneys

Heninger Garrison Davis has successfully represented thousands of individuals who ingested the diet medications Fen-Phen, Redux and Pondimin. We also represent persons who suffer, as a result of ingesting these drugs, the condition known as Primary Pulmonary Hypertension (”PPH”).

THE DANGER

Primary Pulmonary Hypertension (”PPH”) is a serious and potentially life threatening cardiovascular condition. PPH causes high blood pressure in the lungs that produces fatigue, dizzy spells, fainting, chest pain and can create a feeling of breathlessness with the slightest exertion.

A 1996 study in the New England Journal of Medicine found that the use of Fen-Phen for three months or longer can increase the risk of developing PPH by a factor of twenty-three. Other medical research shows that PPH from the use of Fen-Phen, Redux and Pondimin will continue to increase because of the large, initial underestimation of actual patients affected. According to the American Heart Association, an estimated 500 to 1,000 new cases of PPH are diagnosed in the United States each year, mostly in women between the ages of twenty and forty.

SYMPTOMS OF PPH

Typical initial symptoms of PPH are weakness, fatigue, shortness of breath, chest pain, dizzy spells and fainting.

Advanced symptoms of PPH, due especially to delay in diagnosis, can include bluish lips and skin, ankle and lower leg swelling, increased chest pain and even death.

DIFFICULT TO DIAGNOSE

PPH is often misdiagnosed and mistaken for more typical (but less dangerous) conditions. Years can go by without proper diagnosis, allowing the disease to progress into late stages.

WHAT YOU SHOULD DO

If you or a loved one used Fen-Phen, Redux or Pondimin and now suffer any symptoms that might be PPH, please seek medical attention. If you have PPH and took Fen-Phen, Redux or Pondimin, please fill out and submit our confidential questionnaire or contact us by telephone.

Click here for our confidential questionnaire